LivaNova (NASDAQ:LIVN) Releases FY 2024 Earnings Guidance

LivaNova (NASDAQ:LIVN - Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided EPS guidance of 3.300-3.400 for the period, compared to the consensus EPS estimate of 3.160. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.2 billion.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. The Goldman Sachs Group assumed coverage on LivaNova in a research report on Friday, October 4th. They set a "buy" rating and a $65.00 target price on the stock. Needham & Company LLC boosted their target price on shares of LivaNova from $72.00 to $75.00 and gave the stock a "buy" rating in a research report on Wednesday, July 31st. Stifel Nicolaus lifted their price objective on shares of LivaNova from $70.00 to $72.00 and gave the stock a "buy" rating in a research note on Thursday, July 25th. Baird R W raised shares of LivaNova from a "hold" rating to a "strong-buy" rating in a report on Tuesday, September 17th. Finally, Robert W. Baird upgraded LivaNova from a "neutral" rating to an "outperform" rating and raised their target price for the stock from $55.00 to $66.00 in a research note on Tuesday, September 17th. One equities research analyst has rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $69.83.

LivaNova Stock Performance

NASDAQ:LIVN traded down $1.63 during mid-day trading on Wednesday, hitting $51.34. The company's stock had a trading volume of 1,724,838 shares, compared to its average volume of 622,961. The business's fifty day moving average is $50.93 and its two-hundred day moving average is $53.15. The stock has a market cap of $2.78 billion, a price-to-earnings ratio of -85.57 and a beta of 1.00. The company has a debt-to-equity ratio of 0.49, a current ratio of 3.45 and a quick ratio of 2.94. LivaNova has a 1 year low of $42.75 and a 1 year high of $64.47.

LivaNova (NASDAQ:LIVN - Get Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.66 by $0.15. The business had revenue of $318.60 million during the quarter, compared to analysts' expectations of $305.05 million. LivaNova had a positive return on equity of 13.77% and a negative net margin of 1.37%. Analysts anticipate that LivaNova will post 2.58 EPS for the current fiscal year.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.